Morepen Laboratories' Q1FY24 consolidated net profit climbs to Rs. 14.63 crores

Morepen Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 403.4561 crores during the period ended June 30, 2023 as compared to Rs. 366.8080 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 14.6329 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 8.2415 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 0.29 for the period ended June 30, 2023 as compared to Rs. 0.16 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 403.4561 crs	₹366.8080 crs	9.99%
Net Profit	₹14.6329 crs	₹8.2415 crs	77.55%
EPS	₹0.29	₹0.16	81.25%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 403.4561 crores during the period ended June 30, 2023 as compared to Rs.303.3149 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.14.6329 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.5.6299 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.0.29 for the period ended June 30, 2023 as compared to Rs.0.11 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 403.4561 crs	₹303.3149 crs	33.02%
Net Profit	₹14.6329 crs	₹5.6299 crs	159.91%
EPS	₹0.29	₹0.11	163.64%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 30.46 as compared to the previous close of Rs. 30.40. The total number of shares traded during the day was 283874 in over 1030 trades.

The stock hit an intraday high of Rs. 31.00 and intraday low of 30.11. The net turnover during the day was Rs. 8687573.00.

Source : Equity Bulls

Keywords

MorepenLaboratories Q1FY24 ResultUpdate